CCL Capital Fund, LP Information

CCL Capital Advisors, LLC & Playa Vista Equities, LLC serve as the General Parters for CCL Capital Fund, LP. Under no circumstances should any material at this site be used or considered as an offer to sell or a solicitation of any offer to buy an interest in any investment fund managed by CCL Capital Advisors, LLC and Playa Vista Equities, LLC including, but not limited to CCL Capital Fund, LP. Any such offer or solicitation will be made only by means of the Confidential Private Offering Memorandum relating to the particular fund. Access to information about the funds is limited to investors who either qualify as accredited investors within the meaning of the Securities Act of 1933, as amended, or those investors who generally are sophisticated in financial matters, such that they are capable of evaluating the merits and risks of prospective investments. Portfolio management directs holdings with an investment focus on development-stage therapeutics, especially those pursuing orphan indications & unmet medical needs. As a complement to this activity, our Portfolio Manager publishes equity analysis on companies in this space. CCL Capital Fund, LP follows a progressive financial model for hedge funds (No AUM Fee, 6% Hurdle, High-water Mark) & is designed for aggressive growth & preservation of capital in a manner that is uncoupled from the traditional indices. The portfolio seeks differentiated value in stocks, primarily smaller companies between $100M-1B in market capitalization with at least one drug in development between Phase 2 and approval. Investment activities include long/short/derivatives.